1032 50 Pill - yellow round, 6mm
Pill with imprint 1032 50 is Yellow, Round and has been identified as Topiramate 50 mg. It is supplied by Torrent Pharmaceuticals.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1032 50
Topiramate
- Imprint
- 1032 50
- Strength
- 50 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Torrent Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
hypromelloses,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 400,
corn starch,
sodium starch glycolate type A potato,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 13668-0032 (Discontinued) | Torrent Pharmaceuticals Limited |
| 43063-0114 (Discontinued) | PDRX Pharmaceuticals Inc. (repackager) |
Related images for "1032 50"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,333)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.